• Explore the search for CNS-targeted oligonucleotide ligands and shuttle strategies that could match GalNAc’s efficiency in the liver
• Evaluate emerging chemistry, conjugation, and receptor-mediated approaches, including methods to validate and optimize chemical modifications for CNS delivery
• Discuss translational opportunities and challenges in creating next-generation CNS delivery platforms that enable differentiated therapeutic strategies

NEW DATA